Overview
Saudi Arabia’s life sciences and pharmaceutical sectors are developing through investment, localisation, healthcare transformation and innovation. The Kingdom’s expanding healthcare ecosystem is creating opportunities across pharmaceuticals, biotechnology, medical products and related services.
The sector operates within a highly regulated environment and involves considerations around licensing, intellectual property, investment, manufacturing, distribution and commercialisation.
Our Life Sciences & Pharmaceuticals sector group brings together lawyers from our healthcare, intellectual property, corporate, regulatory, commercial, technology and disputes practices.
We advise on foreign investment, licensing and regulatory requirements, intellectual property, technology arrangements, manufacturing and distribution, commercial contracts, corporate transactions and disputes.
